The effectiveness of the antioxidant aminothiol series on the model of multiple sclerosis
- Authors: Okunevich I.V.1
-
Affiliations:
- Institute of Experimental Medicine
- Issue: Vol 16, No 4 (2018)
- Pages: 41-44
- Section: Articles
- URL: https://journals.rcsi.science/RCF/article/view/11086
- DOI: https://doi.org/10.17816/RCF16441-44
- ID: 11086
Cite item
Full Text
Abstract
In the experiments on an reproducible adequate model of multiple sclerosis – experimental autoimmune encephalomyelitis as a result of the creation of pathological condition by immunization of guinea pigs with an encephalitogenic mixture in the complete Freund’s adjuvant, a pronounced inhibitory effect of the Ttriafen preparation was shown. The synthesized preparation of Ttriafen with antihypoxic and antioxidant properties on the experimental autoimmune encephalomyelitis model was used for chronic administration for 35 days, orally at a dose of 50 mg/kg. This drug is known to be free radical scavenger. A number of immunological indices and the clinical picture of neurological complications and the severity of central nervous system damage in experimental guinea pigs were studied. The circulating antibody production was estimated using the complement fixation test. In the peripheral blood, the content of lipid peroxidation products and antioxidant defense enzymes was evaluated. In another series of experiments, the lethality of animals after inoculation of the encephalitogenic mixture in Freund’s complete adjuvant and the protective effect of Triafen’s preparation were reproduced. In the present study, it has been established that the synthetic preparation of the aminothiol Triafen series on the experimental model of multiple sclerosis shows a neuroprotective and immunomodulating property, and increases the resistance to the intensification of LPO processes.
Full Text
##article.viewOnOriginalSite##About the authors
Irina V. Okunevich
Institute of Experimental Medicine
Author for correspondence.
Email: irina_okunevich@mail.ru
PhD (Pharmacology), Senior Researcher
Russian Federation, Saint PetersburgReferences
- Sternberg Z. Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies. Autoimmun Rev. 2016;15(2):113-23. doi: 10.1016/j.autrev.2015.04.012.
- Хныченко Л.К., Окуневич И.В. Противовоспалительная активность гипоксена в эксперименте // Обзоры по клинической фармакологии и лекарственной терапии. - 2015. - Т. 13. - № 3. - С. 35-38. [Khnychenko LK, Okunevich IV. Experimental assessment of inflammatory effect of hypoxen. Reviews on clinical pharmacology and drug therapy. 2015;13(3):35-38. (In Russ.)]. doi: 10.17816/RCF13335-38.
- Coyle PK. Switching algorithms: from one immunomodulatory agent to another. J Neurol. 2008;255(Suppl 1):44-50. doi: 10.1007/s00415-008-1007-3.
- Степаненко Е.М., Вилков Г.А., Крыжановский Г.Н. Состояние перекисного окисления липидов при экспериментальном аллергическом энцефаломиелите // Бюллетень экспериментальной биологии и медицины. - 1984. - Т. 98. - № 9. - С. 336-338. [Stepanenko EM, Vilkov GA, Kryzhanovskiy GN. Lipid peroxidation in experimental allergic encephalomyelitis. Biull Eksp Biol Med. 1984;98(9):336-338. (In Russ.)]
- Беленко Е.А., Воробьева О.В. Особенности вегетативного контроля сердечной деятельности у пациентов с ремиттирующей формой рассеянного склероза // Журнал неврологии и психиатрии им. С.С. Корсакова. - 2012. - Т. 112. - № 3. - С. 68-71. [Belenko EA, Vorob’eva OV. Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis. Zh Nevrol Psikhiatr Im S.S. Korsakova. 2012;112(3);68-71. (In Russ.)]
- Gold R. Combination therapies in multiple sclerosis. J Neurol. 2008;255 Suppl 1:51-60. doi: 10.1007/s00415-008-1008-2.
